Minoxicutan Mã„nner (Minoxidil)

Minoxidil functions as a potassium‑channel opener, causing vasodilation of blood vessels in the scalp. The resulting increased blood flow supplies more oxygen and nutrients to hair follicles, prolonging the growth phase of the hair cycle and encouraging new hair shaft formation.

The appropriate dose of Minoxicutan Männ er is determined by a qualified prescriber based on individual needs and product labeling. Patients should follow the specific instructions provided by their healthcare professional and the product’s package insert.

The safety of Minoxicutan Männ er in pregnancy or while breastfeeding has not been established. Women who are pregnant, planning to become pregnant, or nursing should discuss potential risks with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Minoxicutan Männ er contains minoxidil, the only FDA‑approved topical vasodilator for hair loss. Compared with oral finasteride, which works hormonally, minoxidil acts locally on the scalp and does not affect systemic hormone levels, offering an alternative for patients who prefer topical therapy.

Minoxicutan Männ er should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Apply the recommended amount of Minoxicutan Männ er to a dry scalp twice daily, usually in the morning and evening. Use clean hands, spread the solution evenly over the affected area, and allow it to dry completely before styling or using other hair products.

Serious risks, though rare, include systemic effects such as dizziness, rapid heart rate, or swelling of the hands, feet, or face, which may indicate excessive absorption. If any of these symptoms occur, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to minoxidil or any component of the formulation should avoid using Minoxicutan Männ er. It is also not recommended for people with severe cardiovascular disease without medical supervision, and it should not be applied to broken or inflamed skin.